Concepedia

T. Fashola

TF

Statistics

Publications

6

Citations

858

H-Index

6

Active since

1990

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

UCLouvain

Novartis (United Kingdom)

The University of Sydney

T. Fashola is an author at Novartis (Switzerland) specializing in medicine, bone health, and osteoporosis.

Top concepts

Publications per year

1990–2009

6

Publications

6

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

David M. Reid, Jean‐Pierre Devogelaer, Kenneth G. Saag et al. · The Lancet · 2009 · 525 citations · Full text

, , +5

Long-Term Control of Bone Turnover in Paget's Disease With Zoledronic Acid and Risedronate

David Hosking, Kenneth W. Lyles, Jacques P. Brown et al. · Journal of Bone and Mineral Research · 2006 · 159 citations · Full text

A limited sampling strategy for the measurement of cyclosporine AUC.

A. E. Johnston, Ingrid Sketris, Marsden Jt et al. · PubMed · 1990 · 77 citations

, , +8

Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis

J.-P. Devogelaer, Jacques P. Brown, P. Burckhardt et al. · Osteoporosis International · 2007 · 67 citations

, , +6

Comparable Efficacy and Tolerability of Formoterol (Foradil<sup>®</sup>) Administered via a Novel Multi-Dose Dry Powder Inhaler (Certihaler™) or the Aerolizer<sup>®</sup> Dry Powder Inhaler in Patients with Persistent Asthma

Ronald Dahl, Jacques P.H.M. Creemers, Jan van Noord et al. · Respiration · 2004 · 20 citations

1–5 of 6